The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
Shan WangXiaolin LiuHongwei LvJing YuHuihui LiPublished in: Journal of evidence-based medicine (2024)
CTCs can be used as a biomarker to monitor NSCLC efficacy, predict prognosis and guide follow-up treatment.